http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2709194-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639d2a059d953ebcb8b8b0d49205a7bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 |
| filingDate | 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16969f54d779e9d15b841c8bd7c7a30e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f62c9ce0f3bee929c846c7fa83a451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450fde8e54ea9871ecce530c7297d24c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d1ecac5deb98fa9d450634cf75e958 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d07397e38c2336b66b353d2ad31614be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_321c89f63827ebe15e346d3ea84f90f2 |
| publicationDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2709194-C1 |
| titleOfInvention | N-SPACER-CONTAINING 3,6-BIS-β-DICARBONYL-SUBSTITUTED CARBAZOLES WITH FLUORINATED SUBSTITUTES, FOR USE AS MARKERS AND COMPLEXONS |
| abstract | FIELD: medicine; biology.SUBSTANCE: invention relates to luminescence analysis, particularly for medical diagnostics of biological compounds and structures. Disclosed are compounds which are chelate-forming carbazoles of general formula 1, having two symmetric fluorine-containing β-dicarbonyl substituents in positions 3 and 6, as well as N-carboxyl-containing spacer. Compounds have good chelating ability with respect to ions of rare-earth elements, particularly europium, and form with it intense long-luminescent complexes excited with light with wavelength of 375 nm. Through a carboxyl-containing spacer, direct conjugation with biomolecules can be carried out, as a result of which the compounds can be used as molecular type markers or in the form of nanodispersions in various versions of analysis based on biospecific interactions. Detection of complexes is possible on both solid and liquid phases.R: (CF)CF, where n=0–3; R: H, n=1–6.EFFECT: medical diagnostics of biological compounds and structures.1 cl, 7 dwg, 2 tbl, 7 ex |
| priorityDate | 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.